Nov 12, 2024, 01:12
Donald McDonnell: The directions we are taking to develop new drugs for patients with metastatic prostate cancer
Donald McDonnell, Professor at Department of Pharmacology and Cancer Biology at Duke University School of Medicine, shared a post on LinkedIn:
“Josh Friedman at Healio wrote a very nice piece on the implications of our recent work on androgens/androgen receptor action in prostate cancer.
He also highlighted the clinical studies of Sam Denmeade at Johns Hopkins which support the directions we are taking to develop new drugs for patients with metastatic prostate cancer.
Click here to read more.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 05:54
Dec 21, 2024, 05:42
Dec 21, 2024, 04:55
Dec 21, 2024, 03:42